Point72 Hong Kong’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,252
Closed -$56K 1342
2022
Q3
$56K Buy
3,252
+2,660
+449% +$50.7K ﹤0.01% 1394
2022
Q2
$10K Sell
592
-6,327
-91% -$104K ﹤0.01% 1673
2022
Q1
$117K Buy
6,919
+5,446
+370% +$103K ﹤0.01% 1118
2021
Q4
$40K Sell
1,473
-2,185
-60% -$65.4K ﹤0.01% 1392
2021
Q3
$108K Buy
+3,658
New +$119K ﹤0.01% 1326
2020
Q1
Sell
-1,122
Closed -$16K 1283
2019
Q4
$16K Buy
+1,122
New +$16.2K ﹤0.01% 921

Other funds holding REPL

Point72 Hong Kong's REPL Position: Q4 2022 in Review

Point72 Hong Kong sold out of Replimune Group (REPL) in Q4 2022, closing a stake of 3,252 shares — an estimated $56K sold.

Point72 Hong Kong first reported a position in REPL in Q4 2019 and held it in 6 quarters. The position peaked at $117K in Q1 2022. 135 funds tracked by Wall St. Rank hold REPL as of Q4 2022.

  • Point72 Hong Kong reported no remaining Replimune Group position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,252 Replimune Group shares in Q4 2022, an estimated $56K.
  • Point72 Hong Kong first reported a position in Replimune Group in Q4 2019 and held it in 6 quarters.
  • Point72 Hong Kong's Replimune Group position peaked at $117K in Q1 2022.
  • 135 funds tracked by Wall St. Rank held Replimune Group as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.